![LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei](https://journals.sagepub.com/cms/10.1177/2047487320902750/asset/images/large/10.1177_2047487320902750-fig1.jpeg)
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial - Peter Sever, Ioanna Gouni-Berthold, Anthony Keech, Robert Giugliano, Terje R Pedersen, KyungAh Im, Huei
![Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram](https://www.researchgate.net/publication/315890984/figure/fig1/AS:481840889896961@1491891228481/Low-Density-Lipoprotein-LDL-Cholesterol-Levels-over-Time-Shown-are-median-values-in.png)
Low-Density Lipoprotein (LDL) Cholesterol Levels over Time. Shown are... | Download Scientific Diagram
![Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/71350af0-e2f6-44da-9ab1-c85f69695c73/gr4.jpg)
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | Journal of the American College of Cardiology
![Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity | Arteriosclerosis, Thrombosis, and Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity | Arteriosclerosis, Thrombosis, and](https://www.ahajournals.org/cms/asset/d0998aec-924d-4b07-9c7c-007739aca870/2248ga1.jpg)
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity | Arteriosclerosis, Thrombosis, and
![Biomedicines | Free Full-Text | Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development Biomedicines | Free Full-Text | Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development](https://www.mdpi.com/biomedicines/biomedicines-09-00915/article_deploy/html/images/biomedicines-09-00915-g001.png)
Biomedicines | Free Full-Text | Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development
![Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ef1033f8150845aef0d3a7a32b95aa1935115b5/5-Table3-1.png)
Table 3 from Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. | Semantic Scholar
![LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1af5db12-2c49-496a-aad1-2731599e3612/joim13212-toc-0001-m.jpg)
LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study - Rathsman - 2021 - Journal of Internal Medicine - Wiley Online Library
![SOLVED: Iio test ine emicacy of a new cholesterol-lowenng medication 10 people are selected random Each has their LDL levels measured (shown below has their LDL levels measured again (After). Before) then SOLVED: Iio test ine emicacy of a new cholesterol-lowenng medication 10 people are selected random Each has their LDL levels measured (shown below has their LDL levels measured again (After). Before) then](https://cdn.numerade.com/ask_images/277c81a973c144709a0e1b0c172f7501.jpg)
SOLVED: Iio test ine emicacy of a new cholesterol-lowenng medication 10 people are selected random Each has their LDL levels measured (shown below has their LDL levels measured again (After). Before) then
![Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/b635639f-3eba-4fe7-b8df-7a21f9f620a1/gr1.jpg)
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants - The Lancet Diabetes & Endocrinology
![It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy](https://windsordairy.com/wind/powerpoints/amgen/Slide14.jpg)
It really lowers LDL Cholesterol. How did it perform in a worldwide, 25,564 person research trial? | Windsor Dairy
![Frontiers | Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet Frontiers | Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet](https://www.frontiersin.org/files/Articles/830325/fendo-13-830325-HTML-r1/image_m/fendo-13-830325-g004.jpg)